Latest Articles
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance
Published: June 2, 2025, 6:30 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo
Published: June 2, 2025, 6:30 p.m.
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer - Medical Xpress
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer Medical Xpress
Published: June 2, 2025, 6:20 p.m.
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer | Newswise - Newswise
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer | Newswise Newswise
Published: June 2, 2025, 2:25 p.m.
Molecular Testing in Ovarian and Endometrial Cancer: Evolving Approaches and Best Practices - OncLive
Molecular Testing in Ovarian and Endometrial Cancer: Evolving Approaches and Best Practices OncLive
Published: May 30, 2025, 3:48 p.m.
New AI tools offer non-invasive, personalized diagnosis of endometrial cancer - Devdiscourse
New AI tools offer non-invasive, personalized diagnosis of endometrial cancer Devdiscourse
Published: May 30, 2025, 3:57 a.m.
MSD launches phase 3 Keytruda combo trial in tough-to-treat endometrial cancer in Korea - koreabiomed.com
MSD launches phase 3 Keytruda combo trial in tough-to-treat endometrial cancer in Korea koreabiomed.com
Published: May 30, 2025, 1:52 a.m.
Pap-ctDNA Yields High Sensitivity in Endometrial Cancer - Docwire News
Pap-ctDNA Yields High Sensitivity in Endometrial Cancer Docwire News
Published: May 29, 2025, 7:47 p.m.
Real-World Analysis Informs Future Directions for Evaluating Dostarlimab/Chemotherapy in Advanced Endometrial Cancer - OncLive
Real-World Analysis Informs Future Directions for Evaluating Dostarlimab/Chemotherapy in Advanced Endometrial Cancer OncLive
Published: May 28, 2025, 2:28 p.m.
Bariatric Surgery, Lifestyle Interventions May Cut Endometrial Cancer Risk by 44 Percent: Study Finds - Medical Dialogues
Bariatric Surgery, Lifestyle Interventions May Cut Endometrial Cancer Risk by 44 Percent: Study Finds Medical Dialogues
Published: May 26, 2025, 3:15 p.m.
Link copied to clipboard!